Nrf2 regulates NGF mRNA induction by carnosic acid in T98G glioblastoma cells and normal human astrocytes

Journal of Biochemistry

Volumn 150, Issue 2, 2011, Pages 209-217

  Mimura, Junsei ^a   Kosaka, Kunio ^b   Maruyama, Atsushi ^a   Satoh, Takumi ^c   Harada, Nobuhiko ^a   Yoshida, Hidemi ^a   Satoh, Kei ^a   Yamamoto, Masayuki ^d   Itoh, Ken ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b Osaka City University Medical School   (Japan)

^c IWATE UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

astrocyte; carnosic acid; NGF; Nrf2; oxidative stress

Indexed keywords

CARNOSIC ACID; HEME OXYGENASE 1; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MESSENGER RNA; NERVE GROWTH FACTOR; THIOREDOXIN REDUCTASE 1; TRANSCRIPTION FACTOR NRF2;

ARTICLE; ASTROCYTE; CANCER CELL; CONTROLLED STUDY; GLIOBLASTOMA; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN STABILITY;

ASTROCYTES; CELL LINE, TUMOR; DITERPENES, ABIETANE; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HEME OXYGENASE-1; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NERVE GROWTH FACTOR; NEURONS; NF-E2-RELATED FACTOR 2; PLANT EXTRACTS; RNA, MESSENGER; THIOREDOXIN REDUCTASE 1;

ROSMARINUS OFFICINALIS;

EID: 79961064830     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvr065     Document Type: Article

References (49)

1. Sofroniew, M.V., Howe, C.L., and Mobley, W.C. (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24, 1217-1281 (Pubitemid 32695259)
2. Lad, S.P., Neet, K.E., and Mufson, E.J. (2003) Nerve growth factor: Structure, function and therapeutic implications for Alzheimer's disease. Curr. Drug Targets CNS Neurol. Disord. 2, 315-334
3. Crowley, C., Spencer, S.D., Nishimura, M.C., Chen, K.S., Pitts-Meek, S., Armanini, M.P., Ling, L.H., McMahon, S.B., Shelton, D.L., and Levinson, A.D. (1994) Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell 76, 1001-1011 (Pubitemid 24106381)
4. Huang, E.J. and Reichardt, L.F. (2003) Trk receptors: Roles in neuronal signal transduction. Annu. Rev. Biochem. 72, 609-642 (Pubitemid 36930455)
5. Pshenichkin, S.P. and Wise, B.C. (1995) Okadaic acid increases nerve growth factor secretion, mRNA stability, and gene transcription in primary cultures of cortical astrocytes. J. Biol. Chem. 270, 5994-5999
6. Vigé, X., Costa, E., and Wise, B.C. (1991) Mechanism of nerve growth factor mRNA regulation by interleukin-1 and basic fibroblast growth factor in primary cultures of rat astrocytes. Mol. Pharmacol. 40, 186-192
7. Pshenichkin, S.P., Szekely, A.M., and Wise, B.C. (1994) Transcriptional and posttranscriptional mechanisms involved in the interleukin-1, steroid, and protein kinase C regulation of nerve growth factor in cortical astrocytes. J. Neurochem. 63, 419-428 (Pubitemid 24233672)
8. D'Mello, S.R. and Heinrich, G. (1990) Induction of nerve growth factor gene expression by 12-Otetradecanoyl phorbol 13-acetate. J. Neurochem. 55, 718-721 (Pubitemid 120021651)
9. Neveu, I., Naveilhan, P., Jehan, F., Baudet, C., Wion, D., De Luca, H.F., and Brachet, P. (1994) 1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Brain Res. Mol. Brain Res. 24, 70-76
10. Colangelo, A.M., Johnson, P.F., and Mocchetti, I. (1998) b-adrenergic receptor-induced activation of nerve growth factor gene transcription in rat cerebral cortex involves CCAAT/enhancer-binding protein delta. Proc. Natl Acad. Sci. USA 95, 10920-10925 (Pubitemid 28413169)
11. Friedman, W.J., Thakur, S., Seidman, L., and Rabson, A.B. (1996) Regulation of nerve growth factor mRNA by interleukin-1 in rat hippocampal astrocytes is mediated by NFkappaB. J. Biol. Chem. 271, 31115-31120 (Pubitemid 26408551)
12. Galve-Roperh, I., Sánchez, C., Ségui, B., Haro, A., Díaz- Laviada, I., and Levade, T. (1998) Evidence for the lack of involvement of sphingomyelin hydrolysis in the tumor necrosis factor-induced secretion of nerve growth factor in primary astrocyte cultures. J. Neurochem. 71, 498-505 (Pubitemid 28480396)
13. Galve-Roperh, I., Malpartida, J.M., Haro, A., Brachet, P., and Díaz-Laviada, I. (1997) Regulation of nerve growth factor secretion and mRNA expression by bacterial lipopolysaccharide in primary cultures of rat astrocytes. J. Neurosci. Res. 49, 569-575 (Pubitemid 27381244)
14. Kobayashi, M. and Yamamoto, M. (2006) Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv. Enzyme Regul. 46, 113-140 (Pubitemid 44301353)
15. Motohashi, H. and Yamamoto, M. (2004) Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 10, 549-557 (Pubitemid 39433824)
16. Tong, K.I., Kobayashi, A., Katsuoka, F., and Yamamoto, M. (2006) Two-site substrate recognition model for the Keap1-Nrf2 system: A hinge and latch mechanism. Biol. Chem. 387, 1311-1320 (Pubitemid 44691409)
17. Yu, X. and Kensler, T. (2005) Nrf2 as a target for cancer chemoprevention. Mutat. Res. 591, 93-102 (Pubitemid 41654841)
18. Kwak, M., Wakabayashi, N., and Kensler, T.W. (2004) Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers. Mutat. Res. 555, 133-148 (Pubitemid 39345402)
19. Osburn, W.O. and Kensler, T.W. (2008) Nrf2 signaling: An adaptive response pathway for protection against environmental toxic insults. Mutat. Res. 659, 31-39
20. de Vries, H.E., Witte, M., Hondius, D., Rozemuller, A.J.M., Drukarch, B., Hoozemans, J., and van Horssen, J. (2008) Nrf2-induced antioxidant protection: A promising target to counteract ROS-mediated damage in neurodegenerative disease? Free Radic. Biol. Med. 45, 1375-1383
21. Johnson, J.A., Johnson, D.A., Kraft, A.D., Calkins, M.J., Jakel, R.J., Vargas, M. R., and Chen, P. (2008) The Nrf2-ARE pathway: An indicator and modulator of oxidative stress in neurodegeneration. Ann. N.Y. Acad. Sci. 1147, 61-69
22. Haraguchi, H., Saito, T., Okamura, N., and Yagi, A. (1995) Inhibition of lipid peroxidation and superoxide generation by diterpenoids from Rosmarinus officinalis. Planta Med. 61, 333-336
23. Costa, S., Utan, A., Speroni, E., Cervellati, R., Piva, G., Prandini, A., and Guerra, M. C. (2007) Carnosic acid from rosemary extracts: A potential chemoprotective agent against aflatoxin B1. An in vitro study. J. Appl. Toxicol. 27, 152-159 (Pubitemid 46480582)
24. Rau, O., Wurglics, M., Paulke, A., Zitzkowski, J., Meindl, N., Bock, A., Dingermann, T., Abdel-Tawab, M., and Schubert-Zsilavecz, M. (2006) Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma. Planta Med. 72, 881-887 (Pubitemid 44378949)
25. Poeckel, D., Greiner, C., Verhoff, M., Rau, O., Tausch, L., Hörnig, C., Steinhilber, D., Schubert-Zsilavecz, M., and Werz, O. (2008) Carnosic acid and carnosol potently inhibit human 5-lipoxygenase and suppress pro-inflammatory responses of stimulated human polymorphonuclear leukocytes. Biochem. Pharmacol. 76, 91-97
26. Satoh, T., Kosaka, K., Itoh, K., Kobayashi, A., Yamamoto, M., Shimojo, Y., Kitajima, C., Cui, J., Kamins, J., Okamoto, S., Izumi, M., Shirasawa, T., and Lipton, S. A. (2008) Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1. J. Neurochem. 104, 1116-1131 (Pubitemid 351143643)
27. Kosaka, K., Mimura, J., Itoh, K., Satoh, T., Shimojo, Y., Kitajima, C., Maruyama, A., Yamamoto, M., and Shirasawa, T. (2010) Role of Nrf2 and p62/ZIP in the neurite outgrowth by carnosic acid in PC12h cells. J. Biochem. 147, 73-81
28. Kosaka, K. and Yokoi, T. (2003) Carnosic acid, a component of rosemary (Rosmarinus officinalis L.), promotes synthesis of nerve growth factor in T98G human glioblastoma cells. Biol. Pharm. Bull. 26, 1620-1622 (Pubitemid 41699648)
29. Maruyama, A., Tsukamoto, S., Nishikawa, K., Yoshida, A., Harada, N., Motojima, K., Ishii, T., Nakane, A., Yamamoto, M., and Itoh, K. (2008) Nrf2 regulates the alternative first exons of CD36 in macrophages through specific antioxidant response elements. Arch. Biochem. Biophys. 477, 139-145
30. Watai, Y., Kobayashi, A., Nagase, H., Mizukami, M., McEvoy, J., Singer, J.D., Itoh, K., and Yamamoto, M. (2007) Subcellular localization and cytoplasmic complex status of endogenous Keap1. Genes Cells 12, 1163-1178 (Pubitemid 47500530)
31. Hosoya, T., Maruyama, A., Kang, M., Kawatani, Y., Shibata, T., Uchida, K., Warabi, E., Noguchi, N., Itoh, K., and Yamamoto, M. (2005) Differential responses of the Nrf2-Keap1 system to laminar and oscillatory shear stresses in endothelial cells. J. Biol. Chem. 280, 27244-27250 (Pubitemid 41040764)
32. Devling, T.W.P., Lindsay, C.D., McLellan, L.I., McMahon, M., and Hayes, J.D. (2005) Utility of siRNA against Keap1 as a strategy to stimulate a cancer chemopreventive phenotype. Proc. Natl Acad. Sci. USA 102, 7280A-7285A
33. Satoh, T., Izumi, M., Inukai, Y., Tsutsumi, Y., Nakayama, N., Kosaka, K., Shimojo, Y., Kitajima, C., Itoh, K., Yokoi, T., and Shirasawa, T. (2008) Carnosic acid protects neuronal HT22 Cells through activation of the antioxidant-responsive element in free carboxylic acid- and catechol hydroxyl moieties-dependent manners. Neurosci. Lett. 434, 260-265
34. Veenstra, T.D., Fahnestock, M., and Kumar, R. (1998) An AP-1 site in the nerve growth factor promoter is essential for 1, 25-dihydroxyvitamin D3-mediated nerve growth factor expression in osteoblasts. Biochemistry 37, 5988-5994 (Pubitemid 28196753)
35. Colangelo, A.M., Pani, L., and Mocchetti, I. (1996) Correlation between increased AP-1NGF binding activity and induction of nerve growth factor transcription by multiple signal transduction pathways in C6-2B glioma cells. Brain Res. Mol. Brain Res. 35, 1-10
36. Ohta, K., Kuno, S., Mizuta, I., Fujinami, A., Matsui, H., and Ohta, M. (2003) Effects of dopamine agonists bromocriptine, pergolide, cabergoline, and SKF-38393 on GDNF, NGF, and BDNF synthesis in cultured mouse astrocytes. Life Sci. 73, 617-626 (Pubitemid 36603334)
37. Toyomoto, M., Ohta, M., Okumura, K., Yano, H., Matsumoto, K., Inoue, S., Hayashi, K., and Ikeda, K. (2004) Prostaglandins are powerful inducers of NGF and BDNF production in mouse astrocyte cultures. FEBS Lett. 562, 211-215 (Pubitemid 38388474)
38. Lim, J.H., Kim, K., Kim, S.W., Hwang, O., and Choi, H.J. (2008) Bromocriptine activates NQO1 via Nrf2-PI3K/Akt signaling: Novel cytoprotective mechanism against oxidative damage. Pharmacol. Res. 57, 325-331
39. 2. Mol. Cell. Biol. 24, 36-45 (Pubitemid 38010033)
40. Takei, Y. and Laskey, R. (2008) Interpreting crosstalk between TNF-alpha and NGF: Potential implications for disease. Trends Mol. Med. 14, 381-388
41. Bonini, S., Rasi, G., Bracci-Laudiero, M.L., Procoli, A., and Aloe, L. (2003) Nerve growth factor: Neurotrophin or cytokine? Int. Arch. Allergy Immunol. 131, 80-84 (Pubitemid 36735209)
42. Wakabayashi, N., Itoh, K., Wakabayashi, J., Motohashi, H., Noda, S., Takahashi, S., Imakado, S., Kotsuji, T., Otsuka, F., Roop, D. R., Harada, T., Engel, J.D., and Yamamoto, M. (2003) Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 35, 238-245 (Pubitemid 37363177)
43. Satoh, T., Harada, N., Hosoya, T., Tohyama, K., Yamamoto, M., and Itoh, K. (2009) Keap1/Nrf2 system regulates neuronal survival as revealed through study of keap1 gene-knockout mice. Biochem. Biophys. Res. Commun. 380, 298-302
44. MacLeod, A.K., McMahon, M., Plummer, S.M., Higgins, L.G., Penning, T.M., Igarashi, K., and Hayes, J.D. (2009) Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: Demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds. Carcinogenesis 30, 1571-1580
45. Yoshida, H., Mimura, J., Imaizumi, T., Matsumiya, T., Ishikawa, A., Metoki, N., Tanji, K., Ota, K., Hayakari, R., Kosaka, K., Itoh, K., and Satoh, K. (2011) Edaravone and carnosic acid synergistically enhance the expression of nerve growth factor in human astrocytes under hypoxia/reoxygenation. Neurosci. Res. 69, 291-298
46. Vargas, M.R., Johnson, D.A., Sirkis, D.W., Messing, A., and Johnson, J.A. (2008) Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J. Neurosci. 28, 13574-13581
47. Chen, P., Vargas, M.R., Pani, A.K., Smeyne, R.J., Johnson, D.A., Kan, Y.W., and Johnson, J.A. (2009) Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte. Proc. Natl Acad. Sci. USA 106, 2933-2938
48. Shih, A.Y., Johnson, D.A., Wong, G., Kraft, A. D., Jiang, L., Erb, H., Johnson, J. A., and Murphy, T.H. (2003) Coordinate regulation of glutathione biosynthesis and release by Nrf2-expressing glia potently protects neurons from oxidative stress. J. Neurosci. 23, 3394-3406 (Pubitemid 36531981)
49. Vargas, M.R. and Johnson, J.A. (2009) The Nrf2-ARE cytoprotective pathway in astrocytes. Expert Rev. Mol. Med. 11, e17